New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes

Human Genetics

Volumn 114, Issue 5, 2004, Pages 468-477

  Jagiello, Peter ^a   Gencik, Martin ^b   Arning, Larissa ^a   Wieczorek, Stefan ^a   Kunstmann, Erdmute ^a   Csernok, Elena ^c   Gross, Wolfgang L ^c   Epplen, Joerg T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Apoptosis; HLA; Microsatellite; Wegener's granulomatosis

Indexed keywords

DAXX PROTEIN; DNA; HLA DP ANTIGEN; NUCLEOTIDE; RETINOID X RECEPTOR BETA; HLA DPB1; HLA-DPB1; MICROSATELLITE DNA; PRIMER DNA; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ALLELE; APOPTOSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; GENE LOCATION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSATELLITE MARKER; MULTIFACTORIAL GENETIC DISORDER; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; WEGENER GRANULOMATOSIS; CASE CONTROL STUDY; CHROMOSOME MAP; COMPARATIVE STUDY; GENE; GENE FREQUENCY; GENETICS; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

APOPTOSIS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC SCREENING; GERMANY; HLA-DP ANTIGENS; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; WEGENER GRANULOMATOSIS;

EID: 2542495951     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1092-z     Document Type: Article

References (32)

1. Barcellos LF, Klitz W, Field LL, Tobias R, Bowcock AM, Wilson R, Nelson MP, Nagatomi J, Thomson G (1997) Association mapping of disease loci, by use of a pooled DNA genomic screen. Am J Hum Genet 61:734-747
2. Borgmann S, Endisch G, Hacker UT, Song BS, Fricke H (2003) Proinflammatory genotype of interleukin-1 and interleukin-1 receptor antagonist is associated with ESRD in proteinase 3-ANCA vasculitis patients. Am J Kidney Dis 41:933-942
3. Bosch X, Lopez-Soto A, Morello A, Olmo A, Urbano-Marquez A (1997) Vitamin D metabolite-mediated hypercalcemia in Wegener's granulomatosis. Mayo Clin Proc 72:440-444
4. Carroll SB (2003) Genetics and the making of Homo sapiens. Nature 422:849-857
5. Cechova E, Fazekasova H, Shawkatova I, Buc M (1998) Frequency of the HLA-DPB1 allele in the Slovak population. Bratisl Lek Listy 99:54-57
6. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL (1994) Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244-250
7. Csernok E, Muller A, Gross WL (1999) Immunopathology of ANCA-associated vasculitis. Intern Med 38:759-765
8. Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboue R, Martin JP, Lesavre P (1993) Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 43:1329-1332
9. Gencik M, Meller S, Borgmann S, Fricke H (2000) Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 58:2473-2477
10. Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Compston A, Epplen JT (2002) A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4,666 microsatellite markers. Hum Genet 111:270-277
11. Griffith ME, Pusey CD (1997) HLA genes in ANCA-associated vasculitides. Exp Clin Immunogenet 14:196-205
12. Huang D, Zhou Y, Hoffman GS (2001) Pathogenesis: immunogenetic factors. Best Pract Res Clin Rheumatol 15:239-258
13. Hviid TV, Madsen HO, Morling N (1992) HLA-DPB1 typing with polymerase chain reaction and restriction fragment length polymorphism technique in Danes. Tissue Antigens 40:140-144
14. Jeffreys AJ, Ritchie A, Neumann R (2000) High resolution analysis of haplotype diversity and meiotic crossover in the human TAP2 recombination hotspot. Hum Mol Genet 9:725-733
15. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187-192
16. Kauppi L, Sajantila A, Jeffreys AJ (2003) Recombination hotspots rather than population history dominate linkage disequilibrium in the MHC class II region. Hum Mol Genet 12:33-40
17. Kobayashi SD, Voyich JM, Braughton KR, DeLeo FR (2003) Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J Immunol 170:3357-3368
18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 1101-1107
19. McCanlies EC, Kreiss K, Andrew M, Weston A (2003) HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol 157:388-398
20. Miterski B, Epplen JT, Gencik M (2002) On the genetic contribution to selected multifactorial diseases with autoimmune characteristics. Cell Mol Biol (Noisy-le-grand) 48:331-341
21. Moosig F, Csernok E, Kumanovics G, Gross WL (2000) Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol 122:499-503
22. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
23. Prufer K, Barsony J (2002) Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol 16:1738-1751
24. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES (2001) Linkage disequilibrium in the human genome. Nature 411:199-204
25. Richeldi L, Sorrentino R, Saltini C (1993) HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242-244
26. Savill J, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865-875
27. Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136
28. Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A, Coraddu F, Roxburgh R, Sawcer D, Gray J, Deans J, Goodfellow PN, Walker N, Clayton D, Compston A (2002) A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain 125:1337-1347
29. Schneider S, Roessli D, Excoffier L (2000) Arlequin: a software for population genetics data analysis. Ver 2.000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva
30. van der Geld, YM, Limburg, PC, Kallenberg, CG (2001) Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 69, 177-190
31. Wagner N, Wagner KD, Schley G, Badiali L, Theres H, Scholz H (2003) 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. Exp Eye Res 77:1-9
32. Zhang L, Jayne DR, Zhao MH, Lockwood CM, Oliveira DB (1995) Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int 47:294-298